gsk fda - Search News

Order byBest matchMost fresh

News

GSK shares fall

· 4h · on MSN

GSK shares fall after blood cancer drug likely headed for U.S. rejection

(Reuters) -GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug Blenrep, citing earlier concerns over eye-related side effects. The British drugmaker was trying to revive the drug,

Continue reading

· 5h · on MSN

GSK Falls After FDA Advisory Panel Fails to Back Cancer Drug

GSK blood cancer drug fails to win backing of key US regulatory panel

2h

FDA approves GSK’s prefilled syringe presentation of Shingrix

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

Fierce Pharma2d

As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

3don MSN

GSK seeks FDA nod for expanded use of RSV vaccine in adults

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results